Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Apr 2021 07:00

RNS Number : 6598V
Zoetic International PLC
16 April 2021
 

For immediate release

16 April 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic' or the 'Group')

 

Trading Update

 

Zoetic, the international CBD group, is pleased to provide an update on its operations.

 

Overview

· US rollout continues following October 2020 launch

o Chill products expected to be stocked in over 3,500 stores by July 2021

o Broader consumer base targeted as brand enters new markets

 

· New product launches across both core brands

o Chill brand CBD smokes to launch in the UK during Q2-2021

o New anti-ageing skincare cosmetics line to launch with the new Zoetic website

 

· Product websites due for relaunch in coming weeks

o Thechillway.com to launch with multi-lingual and currency options to facilitate international sales

o Zoetic.com redesigned to cater to the luxury market

 

US rollout

 

The Group is pleased to report that the rollout of its Chill brand of tobacco alternative products continues at considerable speed. Since the announcement on 28 October 2020, further orders have been placed by major distribution partners as the brand expands across the US towards full commercialisation.

 

By July 2021, it is expected that Chill products will be on sale in 3,500 high footfall outlets. This milestone will also mark the Chill brand's full entrance into new high-growth markets including Florida, Georgia, Virginia, North Carolina, Indiana, California, and Missouri.

 

This rollout will continue to ramp up over the course of the next 10 to 12 months and the information gathered during this initial phase will allow Zoetic to guide its strategy.

 

International product launches

 

Zoetic products are set to expand both in terms of range and international availability.

 

This includes Chill-branded CBD smokes, which are tobacco and nicotine-free, entering the UK market for the first time. Consumers will be able to purchase these products during Q2-2021.

 

Additionally, new anti-ageing skincare products have been added to the Zoetic range of cosmetics products. As the brand's line of CBD skincare products continue to attract critical acclaim, the Group anticipates high demand for this new range as Zoetic continues to cement itself as a major contender in the luxury market.

 

Relaunch of product websites

 

As the Group's core CBD brands continue to grow in popularity, its product websites have been redesigned and are now due to relaunch in the coming weeks.

 

The online home of the Chill range of CBD products, thechillway.com, has been equipped with multi-lingual and international currency options to better facilitate worldwide sales as the global market for tobacco-substitute products expands.

 

The Zoetic.com website, which hosts the Group's Zoetic-branded CBD cosmetics products, has been overhauled to specifically cater to the luxury sector. With multi-lingual and various currency options due to follow in the near future, Zoetic will soon be equipped to scale on an international level across its full product range.

 

Trevor Taylor, Co-CEO of Zoetic, said: "This is a busy and exciting time for us as our products enter new regions and we capitalise on the growing health and CBD trends in our key markets. We are particularly enthusiastic about the launch of Chill-brand CBD smokes in the UK, and we are working hard to ensure that their debut in this largely untapped market is a success. The timing for the launch is ideal as we have recently received news that our CBD products passed the Food Standards Agency's administrative check, which all CBD brands in the UK must now pass before they can be sold."

 

Antonio Russo, Co-CEO of Zoetic, added: "With a rapidly growing physical store footprint and encouraging ecommerce sales figures, our products are now reaching more consumers than ever before. As always, we endeavour to provide investors with the opportunity to access this high-growth sector through online channels and landmark distribution agreements. We look forward to updating the market further when we report our full-year results in July."

 

- Ends -

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

 

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

 

Allenby Capital Limited (Financial Adviser and Broker)

 

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

 

Nick Naylor (Corporate Finance)

 

 

Kelly Gardiner (Equity Sales)

 

 

 

Buchanan

 

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

 

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

 

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFTSEIELIL
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.